KCI™, An Acelity Company


Acelity is a global advanced wound care company that leverages the strengths of Kinetic Concepts, Inc. and Systagenix Wound Management, Limited. Available in more than 80 countries, the innovative and complementary Acelity product portfolio delivers value through solutions that speed healing and lead the industry in quality, safety and customer experience. Acelity’s portfolio includes negative pressure wound therapy, advanced wound dressings, negative pressure surgical incision management and epidermal harvesting.
Acelity’s Vision
“Restore People’s Lives.”
Acelity’s Mission
“Our mission is to change the practice of medicine with solutions that advance the science of healing, create economic value and improve patients’ lives.”
Acelity’s Values
“United, Authentic, Purposeful, Courageous”

Helping Patients Heal

Our focus is to improve patient health. Acelity products have a well-documented use history, shown to facilitate healing in the hospital or the home. Acelity has developed a comprehensive range of products and therapies that offer best-in-class solutions and deliver superior clinical outcomes for patients experiencing a wide variety of wounds.

Global Footprint

Acelity is a product market leader within multiple care settings. We are currently present in more than 80 countries across the globe including the USA, Europe, the Middle East and Africa (EMEA) and Asia Pacific regions. We provide service in over 800,000+ clinical procedures annually in more than 30,000 facilities around the world. Acelity is headquartered in San Antonio, Texas, with a team of nearly 5,000 employees globally.

Why We Care

Chronic wounds represent a large and growing threat to public health. In the U.S. alone, chronic wounds impact more than 6.5 million people. As the population ages, that burden is projected to increase – negatively impacted by rising healthcare costs and the growing incidences of diabetes and obesity.

At Acelity, we help improve the lives of patients through innovation. We are also researching and documenting the value of our products in terms of individual and public benefit. This research helps to inform policy – and decision-makers by providing a systematic way to evaluate treatment alternatives.

Innovative Products

Innovation has been integral to Acelity for 60 years. We hold more than 2,700 patents worldwide, and continue to increase that number by about 100 every year. Acelity works in close partnership with the medical community to deliver products that are designed to help speed healing around the world. This involves drawing upon decades of experience with patients and their caregivers as well as our own understanding of wound biology and pathophysiology. Acelity has developed a comprehensive range of products and therapies for a wide variety of wounds, including:
V.A.C.® Therapy Systems
innovative NPWT Systems used to treat more than 10 million wounds around the world in the last decade
NANOVA™ Therapy System and SNAP™ Therapy System
easy to use disposable NPWT Systems for small - medium sized and low - medium exuding wounds
V.A.C.ULTA™ Therapy System with V.A.C. VERAFLO™ Therapy
next generation NPWT System enabled for topical wound solution instillation
PREVENA™ Incision Management System
NPWT product designed for management of closed surgical incisions
CELLUTOME™ Epidermal Harvesting System
advanced device that harvests small areas of epidermis for autologous skin grafting
PROMOGRAN™ Protease Modulating Matrix and PROMOGRAN PRISMA™ Wound Balancing Matrix
specialized dressings that help promote a moist wound environment conducive to wound healing

Commitment to Medical Education

Acelity offers cutting-edge, evidence-based medical education to advance surgical techniques, wound care management, and clinical solutions. We have unprecedented practices for patient healing with more than 1,200 medical education events conducted annually, educating more than 30,000 clinicians each year on our products in order to advance surgical techniques, wound care management, and clinical solutions.

© 2017 KCI Licensing Inc. And Systagenix Wound Managment, Limited. All rights reserved. All trademarks designated herein are proprietary to KCI Licensing, Inc. and Systagenix Wound Management, Limited, its affiliates and/or licensors. PRA000351-R0-EMEA, EN (02/17)